HR or Marketing? Claim Your Free Employer Account
Jan G. J. Van de Winkel, Ph.D. ā President and Chief Executive Officer at Genmab
Executive Bio
Dr. van de Winkel is a co-founder of Genmab and served as President, Research & Development and Chief Scientific Officer of the company until his appointment as President & Chief Executive Officer in 2010. Dr. van de Winkel has more than 25 years of experience in the therapeutic antibody field and served as Vice President and Scientific Director of Medarex Europe prior to Genmab. He is the author of over 300 scientific publications and has been responsible for over 150 patents and pending patent applications.
Dr. van de Winkel holds a professorship of immunotherapy at Utrecht University and also holds M.S. and Ph.D. degrees from the University of Nijmegen.
Dr. van de Winkel is a registered manager of Genmab with the Danish Business Authority.
Dr. van de Winkel holds a professorship of immunotherapy at Utrecht University and also holds M.S. and Ph.D. degrees from the University of Nijmegen.
Dr. van de Winkel is a registered manager of Genmab with the Danish Business Authority.
Executive Team Culture Ratings from Genmab Employees
TOP
30%
Genmab's Executive Team scores in the Top 30%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at GenmabNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at GenmabGenmab's Executive Team at a Glance
Based on 15 ratings, Genmab's employees are satisfied with their Executive Team and give them a āBā or 72/100.
Genmab's Executive Team ranks in the Top 30% of other companies on Comparably that also have 1,001-5,000 Employees.
×